Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rigel Pharmaceuticals

21.06
+0.05000.24%
Pre-market: 20.11-0.9500-4.51%06:50 EDT
Volume:173.82K
Turnover:3.65M
Market Cap:376.39M
PE:10.11
High:21.29
Open:20.98
Low:20.71
Close:21.01
Loading ...

Rigel Pharmaceuticals Inc. to Release Second Quarter 2025 Financial Results

Reuters
·
29 Jul

Rigel Pharmaceuticals Announces New Inducement Grants for Non-Executive Employees Under NASDAQ Rule 5635(c)(4)

Reuters
·
07 Jul

Rigel Pharmaceuticals Inc. to Present at Jefferies Global Healthcare Conference

Reuters
·
28 May

Rigel Pharmaceuticals Approves Equity Plan Amendment

TIPRANKS
·
24 May

Rigel Pharmaceuticals Is Maintained at Neutral by Cantor Fitzgerald

Dow Jones
·
07 May

Rigel Pharma Jump 9.9% Premarket; Guides 'Positive' Net Income in 2025 After Swinging to Profit in Q1

MT Newswires Live
·
07 May

Rigel Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Rigel Pharmaceuticals Q1 EPS $0.63 Beats $0.09 Estimate, Sales $53.30M Beat $43.87M Estimate

Benzinga
·
07 May

BRIEF-Rigel Pharmaceuticals Q1 EPS USD 0.64 Vs. IBES Estimate USD 0.02

Reuters
·
07 May

Rigel Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview

Reuters
·
03 May

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

PR Newswire
·
29 Apr

Rigel (RIGL) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
18 Apr

4 Healthcare Stocks to Buy as the Sector Faces Government Heat

Zacks
·
17 Apr

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

PR Newswire
·
04 Apr

High Growth Tech Stocks in the US for April 2025

Simply Wall St.
·
04 Apr

BUZZ-Rigel climbs on blood disorder drug patent settlement

Reuters
·
27 Mar

Rigel Pharmaceuticals Settles Patent Litigation Over Tavalisse

MT Newswires Live
·
27 Mar

BRIEF-Rigel Announces Settlement Agreement Resolving TAVALISSE® (Fostamatinib Disodium Hexahydrate) Patent Litigation

Reuters
·
27 Mar

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

PR Newswire
·
27 Mar

Rigel Pharmaceuticals Appoints Dr. Frohlich to Board

TIPRANKS
·
11 Mar